BioCentury
ARTICLE | Company News

Dicerna, Kyowa Hakko Kirin deal

August 13, 2012 7:00 AM UTC

Dicerna received an undisclosed milestone payment from Kyowa under an amended 2010 deal to develop and commercialize therapeutics utilizing Dicerna's Dicer Substrate short interfering RNA (DsiRNA) tec...